The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single‐centre series
McMillan A., O'Neill AT., Townsend W., Lambert J., Virchis A., Shah R., Menezes L., Humphries P., Von Both K., Grandage V., Carpenter B., Hough R., Ardeshna KM., Daw S.